GOLDMAN SACHS GROUP INC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8,241
-96.5%
11,706
-95.6%
0.00%
Q1 2023$236,999
+17.7%
264,242
+54.9%
0.00%
Q4 2022$201,303
-86.8%
170,596
-15.5%
0.00%
Q3 2022$1,520,000
-6.1%
201,799
-21.5%
0.00%
Q2 2022$1,619,000
-27.8%
256,973
-4.9%
0.00%
Q1 2022$2,242,000
+12.3%
270,076
-29.8%
0.00%
Q4 2021$1,997,000
-21.5%
384,673
+1.0%
0.00%
-100.0%
Q3 2021$2,545,000
-28.1%
380,975
-8.3%
0.00%0.0%
Q2 2021$3,540,000
-21.3%
415,593
-18.2%
0.00%0.0%
Q1 2021$4,497,000
-33.1%
508,223
-7.2%
0.00%
-50.0%
Q4 2020$6,727,000
+91.0%
547,427
+26.5%
0.00%
+100.0%
Q3 2020$3,522,000
+24.1%
432,668
+46.5%
0.00%0.0%
Q2 2020$2,837,000
+593.6%
295,435
+390.9%
0.00%
Q1 2020$409,000
-74.6%
60,188
-44.2%
0.00%
Q4 2019$1,608,000
+55.2%
107,891
+6.8%
0.00%
Q3 2019$1,036,000
+200.3%
101,043
+210.1%
0.00%
Q2 2019$345,000
-62.5%
32,582
-50.4%
0.00%
Q1 2019$919,000
+107.4%
65,722
+50.6%
0.00%
Q4 2018$443,000
+240.8%
43,626
+303.6%
0.00%
Q3 2018$130,000
-23.1%
10,808
-22.2%
0.00%
Q2 2018$169,000
+45.7%
13,889
+17.6%
0.00%
Q1 2018$116,000
-57.4%
11,810
-65.7%
0.00%
Q2 2017$272,00034,4450.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders